The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
Coronary Artery DiseaseCoronary DiseaseVascular Diseases
Interventions
DEVICE

INVADER™ PTCA Balloon Dilatation Catheter

INVADER™ PTCA Balloon Dilatation Catheter is a single use, EO sterilized, monorail rapid exchange (RX) coronary angioplasty balloon dilatation catheter. The INVADER™ PTCA has been designed to dilate the stenotic atherosclerotic lesions in coronary arteries or bypass grafts. The INVADER™ PTCA is an interventional, non-surgical device, and considered minimally invasive.

Trial Locations (1)

Unknown

Alvimedica, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alvimedica

INDUSTRY

NCT05904951 - The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study | Biotech Hunter | Biotech Hunter